Platelet hyperreactivity, scavenger receptors and atherothrombosis
- PMID: 19630804
- PMCID: PMC2857393
- DOI: 10.1111/j.1538-7836.2009.03422.x
Platelet hyperreactivity, scavenger receptors and atherothrombosis
Abstract
Scavenger receptors (SRs) were initially identified as macrophage receptors that recognize modified lipoproteins. The lists of SRs, their ligands and cells expressing SRs have been significantly extended during the last two decades. What has become clear is that many ligands of SRs are present in vivo only in pathologic conditions. Several SRs have been identified on platelets with the best studied being scavenger receptors CD36 and SR-BI. Platelet SRs are multiligand receptors with properties of pattern recognition receptors. CD36 and SR-BI are exposed on resting platelets, while other SRs are rapidly expressed upon platelet activation. Thus, platelets may serve as sensors of 'pathologic ligands' in circulation. The role of platelet SRs in platelet physiology is still poorly understood. However, the data are accumulating that SR ligands, present in the circulation under pathologic conditions, interact with platelet SR and modulate platelet reactivity, thereby contributing to thrombosis and cardiovascular pathology.
Similar articles
-
Regulation of platelet function by class B scavenger receptors in hyperlipidemia.Arterioscler Thromb Vasc Biol. 2010 Dec;30(12):2350-6. doi: 10.1161/ATVBAHA.110.207498. Epub 2010 Nov 11. Arterioscler Thromb Vasc Biol. 2010. PMID: 21071700 Free PMC article. Review.
-
HDL scavenger receptor class B type I and platelet function.Curr Opin Lipidol. 2011 Aug;22(4):277-82. doi: 10.1097/MOL.0b013e32834701de. Curr Opin Lipidol. 2011. PMID: 21537173 Review.
-
Native high-density lipoproteins inhibit platelet activation via scavenger receptor BI: role of negatively charged phospholipids.Atherosclerosis. 2011 Apr;215(2):374-82. doi: 10.1016/j.atherosclerosis.2010.12.026. Epub 2011 Jan 19. Atherosclerosis. 2011. PMID: 21315353
-
Scavenger receptors: Implications in atherothrombotic disorders.Int J Biochem Cell Biol. 2011 May;43(5):697-700. doi: 10.1016/j.biocel.2011.01.019. Epub 2011 Feb 1. Int J Biochem Cell Biol. 2011. PMID: 21292024 Review.
-
CD36 and macrophage scavenger receptor a modulate foam cell formation via inhibition of lipid-laden platelet phagocytosis.Semin Thromb Hemost. 2010 Mar;36(2):157-62. doi: 10.1055/s-0030-1251499. Epub 2010 Apr 22. Semin Thromb Hemost. 2010. PMID: 20414830
Cited by
-
Editorial: Platelets as Players in Neuropathologies: Novel Diagnostic and Therapeutic Targets.Front Immunol. 2021 Sep 29;12:772352. doi: 10.3389/fimmu.2021.772352. eCollection 2021. Front Immunol. 2021. PMID: 34659273 Free PMC article. No abstract available.
-
Regulation of platelet function by class B scavenger receptors in hyperlipidemia.Arterioscler Thromb Vasc Biol. 2010 Dec;30(12):2350-6. doi: 10.1161/ATVBAHA.110.207498. Epub 2010 Nov 11. Arterioscler Thromb Vasc Biol. 2010. PMID: 21071700 Free PMC article. Review.
-
Platelet Redox Imbalance in Hypercholesterolemia: A Big Problem for a Small Cell.Int J Mol Sci. 2022 Sep 28;23(19):11446. doi: 10.3390/ijms231911446. Int J Mol Sci. 2022. PMID: 36232746 Free PMC article. Review.
-
Antiplatelet Effects of PCSK9 Inhibitors in Primary Hypercholesterolemia.Life (Basel). 2021 May 23;11(6):466. doi: 10.3390/life11060466. Life (Basel). 2021. PMID: 34071103 Free PMC article. Review.
-
High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease.J Lipid Res. 2013 Dec;54(12):3227-43. doi: 10.1194/jlr.R037762. Epub 2013 Jul 20. J Lipid Res. 2013. PMID: 23873269 Free PMC article. Review.
References
-
- Tandon NN, Ockenhouse CF, Greco NJ, Jamieson GA. Adhesive functions of platelets lacking glycoprotein IV (CD36). Blood. 1991;78:2809–13. - PubMed
-
- Hoebe K, Georgel P, Rutschmann S, Du X, Mudd S, Crozat K, Sovath S, Shamel L, Hartung T, Zahringer U, Beutler B. CD36 is a sensor of diacylglycerides. Nature. 2005;433:523–7. - PubMed
-
- Bodart V, Febbraio M, Demers A, McNicoll N, Pohankova P, Perreault A, Sejlitz T, Escher E, Silverstein RL, Lamontagne D, Ong H. CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart. Circ Res. 2002;90:844–9. - PubMed
-
- Podrez EA, Poliakov E, Shen Z, Zhang R, Deng Y, Sun M, Finton PJ, Shan L, Gugiu B, Fox PL, Hoff HF, Salomon RG, Hazen SL. Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36. J Biol Chem. 2002;277:38503–16. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials